Literature DB >> 21779230

Spindle Cell Metaplastic Breast Carcinoma with Leiomyoid Differentiation: A Case Report.

Claudius Conrad1, Diane L Miller, Christina Kaiser, Karl-Walter Jauch, Hanno Nieß, Ralf Huss.   

Abstract

BACKGROUND: Metaplastic carcinoma of the breast is a rare but distinct entity within the group of undifferentiated invasive carcinomas. This entity accounts for less than 0.5% of all breast cancers and contains elements of epithelial (ductal), mesenchymal, and intermediate forms of differentiation. Of these metaplastic carcinomas, there have been reports of chondroid, squamous, osseous, and spindle differentiation. CASE REPORT: We describe the clinical course of a 52-year-old female patient with an unusual histopathology of a spindle cell carcinoma of the breast, discuss the literature, and recommend an approach to diagnosis and treatment. The patient initially presented to an outside hospital with a rapidly growing breast mass that was originally diagnosed as a malignant phylloides tumor. She presented 11 months after the primary treatment with a local subcutaneous relapse. She later developed a local relapse of her metaplastic carcinoma in the chest wall. Extensive histopathological analysis lead to the diagnosis of a spindle cell metaplastic breast carcinoma with leiomyoid differentiation, which has not been described previously.
CONCLUSIONS: Overlap in morphology can lead to a misinterpretation or underdiagnosis of metaplastic carcinomas. However, the prognosis is similar to more common types of breast adenocarcinoma.

Entities:  

Year:  2011        PMID: 21779230      PMCID: PMC3132972          DOI: 10.1159/000329330

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  16 in total

1.  Metaplastic breast carcinoma. Rare form of mammary cancer.

Authors:  A G Huvos; J C Lucas; F W Foote
Journal:  N Y State J Med       Date:  1973-05-01

2.  Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation.

Authors:  Işil Günhan-Bilgen; Ayşenur Memiş; Esin Emin Ustün; Osman Zekioglu; Necmettin Ozdemir
Journal:  AJR Am J Roentgenol       Date:  2002-06       Impact factor: 3.959

3.  Metaplastic carcinomas of the breast. II. Spindle cell carcinoma.

Authors:  E S Wargotz; P H Deos; H J Norris
Journal:  Hum Pathol       Date:  1989-08       Impact factor: 3.466

4.  Metaplastic carcinoma of the breast: a retrospective review.

Authors:  Giatri Dave; Harry Cosmatos; Tri Do; Kenneth Lodin; Dolly Varshney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-24       Impact factor: 7.038

5.  Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

Authors:  S Leibl; F Moinfar
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

6.  Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence.

Authors:  H Gobbi; J F Simpson; A Borowsky; R A Jensen; D L Page
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

7.  Metaplastic carcinoma of the breast: mammographic and sonographic findings.

Authors:  J M Park; B K Han; W K Moon; Y H Choe; S H Ahn; G Gong
Journal:  J Clin Ultrasound       Date:  2000-05       Impact factor: 0.910

8.  An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

Authors:  Barbara Dunne; Andrew H S Lee; Sarah E Pinder; Jane A Bell; Ian O Ellis
Journal:  Hum Pathol       Date:  2003-10       Impact factor: 3.466

Review 9.  Spindle cell lesions of the breast--the pathologic differential diagnosis.

Authors:  Gary M K Tse; Puay Hoon Tan; Philip C W Lui; Thomas C Putti
Journal:  Breast Cancer Res Treat       Date:  2007-07-18       Impact factor: 4.872

10.  Metaplastic breast carcinomas are basal-like tumours.

Authors:  J S Reis-Filho; F Milanezi; D Steele; K Savage; P T Simpson; J M Nesland; E M Pereira; S R Lakhani; F C Schmitt
Journal:  Histopathology       Date:  2006-07       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.